Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Kent

Showing results (11-20 of 390) with videos related to

Pageof 39
Sort By:
Ebiomedicine|September 18, 2021
Vaccination after prior COVID-19 infection: Implications for dose sparing and booster shotsStephen J Kent, Jennifer A Juno
Immunology and Cell Biology|April 26, 2017
Expanding role for type I Interferons in restricting HIV growthStephen J Kent, Anthony D Kelleher
Immunology and Cell Biology|January 9, 2020
The protective potential of Fc-mediated antibody functions against influenza virus and other viral pathogensHillary A Vanderven, Stephen J Kent
Ebiomedicine|December 3, 2015
Paradox of Protection: Preferential Recognition of CD4-induced Epitopes by Anti-HIV-1 ADCC AntibodiesMatthew S Parsons, Stephen J Kent
Current Opinion in HIV and AIDS|December 2, 2017
Anti-HIV-1 antibody-dependent cellular cytotoxicity: is there more to antibodies than neutralization?Wen Shi Lee, Stephen J Kent
Sexual Health|December 13, 2005
Genetic influences on HIV infection: implications for vaccine developmentMiranda Z Smith, Stephen J Kent
Ebiomedicine|September 27, 2016
Twist in the Tail: Escape from HIV Neutralising Antibodies at a Single Site Confers Broad Susceptibility to OthersAdam K Wheatley, Stephen J Kent
Immunity|October 11, 2023
Strength in diversity: Widening B cell recruitment for broader vaccine protectionAdam K Wheatley, Stephen J Kent
The Lancet. HIV|May 14, 2019
Moving the HIV vaccine field forward: concepts of protective immunityStephen J Kent, Miles P Davenport
Ebiomedicine|November 28, 2017
A Role for Fc-Mediated Humoral Immunity in Reducing HIV Transmission Rates between HIV Serodiscordant Heterosexual CouplesStephen J Kent, Amy W Chung
Pageof 39

Showing results (11-20 of 390) with videos related to

Sort By:
Pageof 39
Ebiomedicine|September 18, 2021
Vaccination after prior COVID-19 infection: Implications for dose sparing and booster shotsStephen J Kent, Jennifer A Juno
Immunology and Cell Biology|April 26, 2017
Expanding role for type I Interferons in restricting HIV growthStephen J Kent, Anthony D Kelleher
Immunology and Cell Biology|January 9, 2020
The protective potential of Fc-mediated antibody functions against influenza virus and other viral pathogensHillary A Vanderven, Stephen J Kent
Ebiomedicine|December 3, 2015
Paradox of Protection: Preferential Recognition of CD4-induced Epitopes by Anti-HIV-1 ADCC AntibodiesMatthew S Parsons, Stephen J Kent
Current Opinion in HIV and AIDS|December 2, 2017
Anti-HIV-1 antibody-dependent cellular cytotoxicity: is there more to antibodies than neutralization?Wen Shi Lee, Stephen J Kent
Sexual Health|December 13, 2005
Genetic influences on HIV infection: implications for vaccine developmentMiranda Z Smith, Stephen J Kent
Ebiomedicine|September 27, 2016
Twist in the Tail: Escape from HIV Neutralising Antibodies at a Single Site Confers Broad Susceptibility to OthersAdam K Wheatley, Stephen J Kent
Immunity|October 11, 2023
Strength in diversity: Widening B cell recruitment for broader vaccine protectionAdam K Wheatley, Stephen J Kent
The Lancet. HIV|May 14, 2019
Moving the HIV vaccine field forward: concepts of protective immunityStephen J Kent, Miles P Davenport
Ebiomedicine|November 28, 2017
A Role for Fc-Mediated Humoral Immunity in Reducing HIV Transmission Rates between HIV Serodiscordant Heterosexual CouplesStephen J Kent, Amy W Chung
Pageof 39